Konrad Lewandowski
Overview
Explore the profile of Konrad Lewandowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lewandowski K, Lukas M, Kaniewska M, Tulewicz-Marti E, Karlowicz K, Bednarczuk A, et al.
Gastrointest Endosc
. 2025 Mar;
PMID: 40044092
Background And Aims: Intestinal strictures are a common and serious complication of inflammatory bowel disease (IBD). Endoscopic balloon dilatation (EBD) is the first step treatment to avoid the surgery. The...
2.
Lewandowski K, Kaniewska M, Karlowicz K, Wiecek M, Tulewicz-Marti E, Celmer P, et al.
Prz Gastroenterol
. 2025 Jan;
16(4):397-407.
PMID: 39810871
Introduction: Ophthalmological manifestations (O-EIM) are one of the extraintestinal manifestations (EIM) of inflammatory bowel disease (IBD), although their frequency and potential relationship with disease activity and treatment remain underestimated. Aim:...
3.
Lewandowski K, Kaniewska M, Tulewicz-Marti E, Gluszek-Osuch M, Ciechanowicz P, Walecka I, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274426
: Oncological anxiety associated with biological therapy is a particular challenge in inflammatory bowel disease (IBD), and it has raised questions about the need for the dermatological assessment of the...
4.
Lewandowski K, Kaniewska M, Wiecek M, Panufnik P, Tulewicz-Marti E, Gluszek-Osuch M, et al.
Pol Arch Intern Med
. 2024 Jul;
134(7-8).
PMID: 38949562
Introduction: There are scarce data on the occurrence of dermal lesions in patients with inflammatory bowel disease (IBD) treated with anti-tumor necrosis factor α (anti-TNF‑α) antibodies. Characteristics of the skin...
5.
Karlowicz K, Lewandowski K, Tulewicz-Marti E, Maciejewska K, Tworek A, Stepien-Wrochna B, et al.
Prz Gastroenterol
. 2024 Jun;
19(2):198-205.
PMID: 38939061
Introduction: Inflammatory bowel disease (IBD) patients use a wide variety of immunosuppressive drugs, including biologics, but their effect on SARS-CoV-2 vaccine antibody levels remains a mystery. Aim: We analysed whether...
6.
Szkutnik-Fiedler D, Szalek E, Otto F, Czyrski A, Karazniewicz-Lada M, Wolc A, et al.
Pharmacol Rep
. 2024 Apr;
76(5):1184-1195.
PMID: 38632186
Background: Regorafenib is used in the treatment of colorectal cancer and hepatocellular carcinoma. Due to the co-morbidity of hyperlipidemia in these conditions, statins, including atorvastatin, are used as potential adjuvant...
7.
Nazarewska A, Lewandowski K, Kaniewska M, Tulewicz-Marti E, Wiecek M, Szwarc P, et al.
Prz Gastroenterol
. 2023 Aug;
18(2):175-182.
PMID: 37538287
Introduction: It is known that the virus SARS-CoV-2 can attack the gastrointestinal (GI) tract and induce gastroenteritis. This can trigger a wide variety of disorders of gut-brain interaction (DGBIs) or...
8.
Tulewicz-Marti E, Stepien-Wrochna B, Maciejewska K, Lodyga M, Karlowicz K, Lewandowski K, et al.
J Pers Med
. 2023 Jun;
13(6).
PMID: 37373902
Introduction: Patients with Inflammatory Bowel Disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are at high risk of developing malignancies, so prevention and adherence to cancer screening may...
9.
Lewandowski K, Kaniewska M, Rosolowski M, Rydzewska G
Prz Gastroenterol
. 2023 Apr;
18(1):61-66.
PMID: 37007763
SARS-CoV-2 infection manifests mainly by involving the respiratory system. Due to the presence of abdominal symptoms, the digestive system is clearly involved in the expression, transmission, and possible pathogenesis of...
10.
Tulewicz-Marti E, Szwarc P, Wiecek M, Lewandowski K, Korcz T, Cicha M, et al.
J Pers Med
. 2023 Mar;
13(3).
PMID: 36983640
Introduction: Anaemia and bone metabolism alterations are common in inflammatory bowel disease (IBD), which is a heterogeneous group of diseases that include Crohn's disease (CD) and ulcerative colitis (UC) with...